Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 20, 2024Open Access

Designing and bioengineering of CDRs with higher affinity against receptor-binding domain (RBD) of SARS-CoV-2 Omicron variant

View Full Paper
Ask AI
Bookmark
Share

Authors

VSVishakha SinghSCShweta ChoudharyMBMandar Bhutkar

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Singh et al. (2024) studied this question.

synapsesocial.com/papers/68e57d47b6db64358751ce07https://doi.org/10.1101/2024.09.19.613860
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1From immune evasion to broad 2025 · 1 citations
  2. 2Enhancing affinity of neutralizing SARS-CoV-2 nanobody through facile structure-guided mutations in CDRs2024 · 3 citations
  3. 3BPS2026 – Covariance-based MD simulation analysis pinpoints nanobody attraction and repulsion sites in SARS-CoV-2 Omicron spike protein2026
  4. 4Structure-Guided Redesign of RBD-Specific Antibodies to ImproveBinding Affinity to SARS-CoV-2 Sublineages2026
  5. 5Iterative In Silico Screening for Optimizing Stable Conformation of Anti-SARS-CoV-2 Nanobodies2024 · 6 citations